BLBenjamin L. EbertJun 26, 2026New paperautoPaperA Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II InhibitionJournal of the American Chemical Society · 2026 · Ji Hyeon Kim, Caitlin E Mills, Zuzanna Kozicka et al.